
|Articles|December 15, 2022
Procipient® :A versatile Excipient for Parenteral Drug Delivery
Author(s)Gaylord
The objective of this white paper is to discuss the suitability of this versatile excipient in parenteral drug products and provide an updated summary of regulated parenteral drug delivery products in which DMSO is incorporated. It will also summarize emerging technologies in which DMSO is instrumental, primarily in the formulation / delivery of peptide drugs and biopolymers.
Trending on Pharmaceutical Technology
1
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Managing Global Trial Supply Risk: Expert Insights
4
How to Vet Importer of Record Partners for Clinical Trials
5
